These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 11280134)

  • 41. Effects of treatment of hypertension on cardiovascular outcome in type 2 diabetes.
    Migdalis IN
    Res Commun Mol Pathol Pharmacol; 2006; 119(1-6):105-14. PubMed ID: 17974100
    [No Abstract]   [Full Text] [Related]  

  • 42. A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus.
    Bangalore S; Parkar S; Grossman E; Messerli FH
    Am J Cardiol; 2007 Oct; 100(8):1254-62. PubMed ID: 17920367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical inquiries. Are there big differences among beta-blockers in treating essential hypertension?
    Sontheimer D; Hitchcock K; Saseen J
    J Fam Pract; 2007 Apr; 56(4):312-4. PubMed ID: 17403332
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparative effectiveness of antihypertensive drugs in patients with diabetes.
    Wu HY; Hung KY; Tu YK; Chien KL
    J Comp Eff Res; 2014 May; 3(3):213-5. PubMed ID: 24969144
    [No Abstract]   [Full Text] [Related]  

  • 45. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH
    Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Type 2 diabetes and nephropathy--new studies, new treatment strategies?].
    Os I; Stenehjem A; Høieggen A; Draganov B; Jenssen T; Holdaas H
    Tidsskr Nor Laegeforen; 2002 Apr; 122(9):918-20. PubMed ID: 12082835
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hypertensive patient with diabetes. "Blood pressure cosmetics" are not enough here].
    MMW Fortschr Med; 2002 Jun; 144(24):53. PubMed ID: 12138889
    [No Abstract]   [Full Text] [Related]  

  • 48. LIFE and SCOPE: what guidance do they offer alongside ALLHAT and ANBP2?
    Nicholls MG
    J Hum Hypertens; 2004 May; 18(5):295-300. PubMed ID: 14739907
    [No Abstract]   [Full Text] [Related]  

  • 49. CAPPP trial. Captopril Prevention Project.
    Messerli FH; Grossman E
    Lancet; 1999 May; 353(9166):1794-5; author reply 1795-6. PubMed ID: 10348012
    [No Abstract]   [Full Text] [Related]  

  • 50. [LIFE study proves preventive action. With losartan to do even more against stroke].
    Baumgart P
    MMW Fortschr Med; 2003; 145 Suppl 1():7-8. PubMed ID: 12958796
    [No Abstract]   [Full Text] [Related]  

  • 51. Hypertension in diabetes.
    Vijan S
    Clin Evid; 2005 Dec; (14):491-500. PubMed ID: 16620417
    [No Abstract]   [Full Text] [Related]  

  • 52. Renal diseases in diabetes mellitus.
    Kumar PD; Rajaratnam K
    J Indian Med Assoc; 1997 Jul; 95(7):426-8. PubMed ID: 9425845
    [No Abstract]   [Full Text] [Related]  

  • 53. [Beta receptor blocking agents, insulin and hypoglycemia].
    Froland A
    Ugeskr Laeger; 1976 Nov; 138(47):2970. PubMed ID: 10661
    [No Abstract]   [Full Text] [Related]  

  • 54. [Coronary artery disease in patients with diabetes mellitus and its treatment].
    Teramoto T
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():94-9. PubMed ID: 11989270
    [No Abstract]   [Full Text] [Related]  

  • 55. CAPPP trial. Captopril Prevention Project.
    Wiggam MI; Atkinson AB; Bell PM
    Lancet; 1999 May; 353(9166):1794; author reply 1795-6. PubMed ID: 10348011
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effect of the angiotensin I-converting enzyme inhibitor captopril in hypertensive diabetics without nephropathy].
    Gómez Reyes D; Rojas Hidalgo E
    Med Clin (Barc); 1988 Apr; 90(13):531-4. PubMed ID: 3292860
    [No Abstract]   [Full Text] [Related]  

  • 57. An economic evaluation of atenolol vs. captopril in patients with type 2 diabetes (UKPDS 24).
    Caro JJ; Lee K
    Curr Hypertens Rep; 2002 Dec; 4(6):417. PubMed ID: 12419165
    [No Abstract]   [Full Text] [Related]  

  • 58. An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).
    Gray A; Clarke P; Raikou M; Adler A; Stevens R; Neil A; Cull C; Stratton I; Holman R;
    Diabet Med; 2001 Jun; 18(6):438-44. PubMed ID: 11472461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic effects of antihypertensive treatment with beta-blockers.
    Sawicki PT; Berger M
    J Intern Med Suppl; 1991; 735():97-9. PubMed ID: 1675055
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between antihypertensive drug use and hypoglycemia: a case-control study of diabetic users of insulin or sulfonylureas.
    Thamer M; Ray NF; Taylor T
    Clin Ther; 1999 Aug; 21(8):1387-400. PubMed ID: 10485510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.